Clinical Trial Update: Serum circ_DLGAP4, lncRNA KCNQ1OT1, and Their Targets by Erythropoietin Resistance in Chronic Kidney Disease

View source ↗

Summary

A completed clinical trial by Ain Shams University investigating serum circ_DLGAP4, lncRNA KCNQ1OT1, and their targets in erythropoietin resistance among patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Snippet

Sponsor: Ain Shams University | Conditions: Chronic Kidney Disease Requiring Hemodialysis, Chronic Kidney Disease | Status: COMPLETED